Nevertheless, a breadth of other CSF synaptic biomarker increases have been shown in AD patients but their specific mechanistic meaning and contribution to AD pathophysiology remains elusive, including a dedicated analysis of the underlying mechanisms that drive CSF GAP-43 increases in AD15,16,18,47,49. Here, GAP43 is linked to Alzheimer disease.